Tranquility Partners LLC increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 7.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,341 shares of the medical device company’s stock after buying an additional 620 shares during the period. Tranquility Partners LLC’s holdings in Cooper Companies were worth $1,031,000 at the end of the most recent quarter.
Several other institutional investors also recently modified their holdings of COO. Envestnet Portfolio Solutions Inc. grew its stake in Cooper Companies by 43.1% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 35,233 shares of the medical device company’s stock worth $3,076,000 after purchasing an additional 10,616 shares during the period. Axxcess Wealth Management LLC boosted its holdings in shares of Cooper Companies by 298.4% in the 1st quarter. Axxcess Wealth Management LLC now owns 8,211 shares of the medical device company’s stock worth $833,000 after buying an additional 6,150 shares during the last quarter. Public Employees Retirement Association of Colorado grew its position in shares of Cooper Companies by 298.9% during the 1st quarter. Public Employees Retirement Association of Colorado now owns 245,793 shares of the medical device company’s stock valued at $24,938,000 after acquiring an additional 184,171 shares during the period. Diversify Advisory Services LLC bought a new position in Cooper Companies during the second quarter valued at $501,000. Finally, BDF Gestion bought a new position in Cooper Companies during the second quarter worth about $2,919,000. Institutional investors own 24.39% of the company’s stock.
Insider Activity
In other news, CEO Albert G. White III sold 114,992 shares of the company’s stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the sale, the chief executive officer now owns 165,273 shares of the company’s stock, valued at $18,267,624.69. This represents a 41.03 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CAO Agostino Ricupati sold 1,601 shares of the firm’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the transaction, the chief accounting officer now directly owns 4,818 shares in the company, valued at approximately $520,488.54. The trade was a 24.94 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 256,373 shares of company stock valued at $27,637,427 in the last ninety days. 2.00% of the stock is currently owned by company insiders.
Wall Street Analysts Forecast Growth
Cooper Companies Stock Down 0.2 %
Cooper Companies stock opened at $99.48 on Tuesday. The Cooper Companies, Inc. has a 12 month low of $82.21 and a 12 month high of $112.38. The stock has a fifty day simple moving average of $106.66 and a two-hundred day simple moving average of $98.12. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33. The firm has a market cap of $19.81 billion, a price-to-earnings ratio of 55.27, a PEG ratio of 2.15 and a beta of 0.99.
Cooper Companies (NASDAQ:COO – Get Free Report) last announced its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The firm had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.84 earnings per share. Equities analysts predict that The Cooper Companies, Inc. will post 3.65 EPS for the current fiscal year.
About Cooper Companies
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Recommended Stories
- Five stocks we like better than Cooper Companies
- What is the Shanghai Stock Exchange Composite Index?
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Investing in Commodities: What Are They? How to Invest in Them
- Applied Materials Market Capitulates: Now is the Time to Buy
- With Risk Tolerance, One Size Does Not Fit All
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.